Cargando…

Efficacy and safety of emapalumab in macrophage activation syndrome

OBJECTIVES: Macrophage activation syndrome (MAS) is a severe, life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). The objective of this study was to confirm the adequacy of an emapalumab dosing regimen in relation to interferon-γ (IF...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Benedetti, Fabrizio, Grom, Alexei A, Brogan, Paul A, Bracaglia, Claudia, Pardeo, Manuela, Marucci, Giulia, Eleftheriou, Despina, Papadopoulou, Charalampia, Schulert, Grant S, Quartier, Pierre, Antón, Jordi, Laveille, Christian, Frederiksen, Rikke, Asnaghi, Veronica, Ballabio, Maria, Jacqmin, Philippe, de Min, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314091/ https://www.ncbi.nlm.nih.gov/pubmed/37001971 http://dx.doi.org/10.1136/ard-2022-223739

Ejemplares similares

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach
por: Jacqmin, Philippe, et al.
Publicado: (2021)

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019)

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020)

Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)
por: Merli, Pietro, et al.
Publicado: (2020)

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
por: Schuelke, Matthew R., et al.
Publicado: (2023)

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Arduini, Alessia, et al.
Publicado: (2019)

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
por: Tucci, Francesca, et al.
Publicado: (2020)

Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis
por: Glintborg, Bente, et al.
Publicado: (2019)

Differential monocyte microrna expression profiles in children with active systemic juvenile idiopathic arthritis
por: Schulert, Grant, et al.
Publicado: (2014)

Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model
por: Bracaglia, Claudia, et al.
Publicado: (2014)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Vasculitis update: pathogenesis and biomarkers
por: Brogan, Paul, et al.
Publicado: (2017)

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
por: Bracaglia, C, et al.
Publicado: (2015)

Therapeutic advances in the treatment of vasculitis
por: Eleftheriou, Despina, et al.
Publicado: (2016)

Vasculitis in children
por: Eleftheriou, Despina, et al.
Publicado: (2009)

The Molecular Biology and Treatment of Systemic Vasculitis in Children
por: Eleftheriou, Despina, et al.
Publicado: (2012)

P03-012 - A P268S NOD2 mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

P02-016 - A novel PSMB8 mutation causing candle syndrome
por: Messia, V, et al.
Publicado: (2013)

P02-031 - Phenotype of V198M and Q703K NLRP3 variants
por: Messia, V, et al.
Publicado: (2013)

PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome
por: Insalaco, A, et al.
Publicado: (2013)

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

PReS-FINAL-2200: Phenotype of V198M and Q703K NLRP3 variants
por: Messia, V, et al.
Publicado: (2013)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

Self-evidence-based digital care programme improves health-related quality of life in adults with a variety of autoimmune diseases and long COVID: a retrospective study
por: Bundy, Nicole, et al.
Publicado: (2023)

Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus
por: De Matteis, Arianna, et al.
Publicado: (2021)

Mechanical Circulatory Support for Right Ventricular Failure
por: DeFilippis, Ersilia M, et al.
Publicado: (2022)

Remote Patient Monitoring for Patients with Heart Failure: Sex- and Race-based Disparities and Opportunities
por: Mastoris, Ioannis, et al.
Publicado: (2023)

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
por: Prencipe, Giusi, et al.
Publicado: (2019)

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients
por: Richi, Patricia, et al.
Publicado: (2019)

Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report
por: AlAhmari, Ali, et al.
Publicado: (2023)

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
por: Curtis, Jeffrey R, et al.
Publicado: (2019)

Treatment of hypertension with angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross‐sectional study
por: Pedrianes‐Martin, Pablo B., et al.
Publicado: (2021)

P02-032 - CAPS: a novel mutation and an unusual phenotype
por: Insalaco, A, et al.
Publicado: (2013)

P01-050 – Anakinra in systemic JIA: single center experience
por: Pardeo, M, et al.
Publicado: (2013)

Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2023)

Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews
por: Rodriguez-García, Sebastián Cruz, et al.
Publicado: (2021)

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022)

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
por: Briot, Karine, et al.
Publicado: (2021)

Involvement of the IFN-gamma pathway in a patient with candle syndrome carrying a novel variant of PSMB8 gene
por: Insalaco, Antonella, et al.
Publicado: (2014)

Cronic non-bacterial osteomyelitis (CNO) in a cohort of pediatric patients: clinical, biological and radiological response to treatment with Anakinra
por: Pardeo, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_94p84rofgb62lj79qusre1aep7